| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.32B | 61.82B | 61.58B | 60.16B | 57.78B | 54.48B |
| Gross Profit | 7.19B | 6.95B | 6.85B | 6.66B | 6.12B | 6.28B |
| EBITDA | 2.45B | 2.35B | 2.39B | 2.38B | 2.24B | 2.16B |
| Net Income | 1.21B | 1.29B | 1.41B | 1.39B | 1.20B | 1.16B |
Balance Sheet | ||||||
| Total Assets | 36.90B | 36.30B | 33.14B | 31.35B | 30.11B | 28.44B |
| Cash, Cash Equivalents and Short-Term Investments | 4.27B | 3.58B | 2.75B | 4.18B | 3.01B | 3.21B |
| Total Debt | 3.30B | 2.46B | 320.00M | 190.00M | 360.00M | 290.00M |
| Total Liabilities | 11.91B | 11.49B | 8.98B | 9.13B | 9.10B | 8.30B |
| Stockholders Equity | 24.96B | 24.78B | 24.13B | 22.19B | 20.99B | 20.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.05B | -1.35B | 1.58B | -91.04M | 1.23B |
| Operating Cash Flow | 0.00 | 2.47B | 120.46M | 1.95B | 746.81M | 1.40B |
| Investing Cash Flow | 0.00 | -3.53B | -1.46B | -387.12M | -817.73M | -505.43M |
| Financing Cash Flow | 0.00 | 1.90B | -89.69M | -385.62M | -137.30M | -290.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥197.09B | 7.25 | ― | 2.18% | 6.76% | 30.90% | |
76 Outperform | ¥204.93B | 13.07 | ― | 3.01% | 8.62% | 43.25% | |
70 Neutral | ¥10.74B | 12.05 | ― | 2.60% | -8.23% | -7.49% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥171.87B | -33.75 | ― | 1.77% | 18.80% | -479.12% | |
57 Neutral | ¥180.74B | 8.93 | ― | 1.44% | 0.66% | 114.22% | |
53 Neutral | ¥32.24B | 136.89 | ― | 3.11% | 1.00% | ― |